Screener
Kura Oncology KURA Shares (Diluted)
Shares (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.
The source filing: Kura Oncology’s 10-Q, filed May 12, 2026. Open the filing →
- Filed
- May 12, 2026, 4:15 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219481
FAQ
- What is Kura Oncology's shares (diluted)?
- Kura Oncology (KURA) reported shares (diluted) of 88.6M in Q1 2026.
- How has Kura Oncology's shares (diluted) changed year-over-year?
- Kura Oncology's shares (diluted) increased by 1.4% year-over-year, from 87.4M to 88.6M.
- What is the long-term trend for Kura Oncology's shares (diluted)?
- Over 4 years (2021 to 2025), Kura Oncology's shares (diluted) has grown at a 7.2% compound annual growth rate (CAGR), from 265.2M to 350.3M.
- What does shares (diluted) mean?
- The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.
Ask your AI about Kura Oncology's shares (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude